Medication-overuse headache in Japan

Cephalalgia

Volumn 28, Issue 11, 2008, Pages 1227-1228

  Kanki, R ^a,b   Nagaseki, Y ^c   Sakai, F ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Tenriyorozu Hospital   (Japan)

^c Nagaseki Headache Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; CAFFEINE; CODEINE; ERGOTAMINE; NON PRESCRIPTION DRUG;

CLINICAL PRACTICE; CULTURAL FACTOR; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; HEADACHE; HUMAN; JAPAN; MIGRAINE; PREVALENCE; PRIMARY HEADACHE; SHORT SURVEY;

FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; JAPAN; MALE;

EID: 53549110489     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01736.x     Document Type: Short Survey

References (5)

1. Imai N, Kitamura E, Konishi T, Y Suzuki Y, Serizawa M, Okabe T. Clinical features of probable medication-overuse headache: a retrospective study in Japan. Cephalalgia 2007 27 : 1020 3.
2. Hara H, Morita T, Sukamoto T, Cutrer FM. Lomerizine (KB2796), a new antimigraine drug. CNS Drug Rev 1995 1 : 204 26.
3. Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia 1997 17 : 15 22.
4. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004 3 : 476 83.
5. Takase Y, Kishigami H, Nakano M, Tatsumi C. Long-term prognosis of analgesics abuse headache. Rinsho Shinkeigaku 2005 45 : 629 33.